Free Trial

Amphastar Pharmaceuticals (AMPH) Earnings Date, Estimates & Call Transcripts

Amphastar Pharmaceuticals logo
$24.50 +0.62 (+2.60%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$24.50 0.00 (-0.02%)
As of 05/2/2025 06:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Amphastar Pharmaceuticals Earnings Summary

Upcoming Q3
Earnings Date
May. 7After Market ClosesEstimated
Consensus EPS
(Aug. 7)
$0.75
Actual EPS
(Aug. 7)
$0.85 Beat By $0.10
Actual Revenue
(Aug. 7)
$182.39M

Amphastar Pharmaceuticals released Q2 2024 earnings on August 7, 2024, reporting an EPS of $0.85, which beat the consensus estimate of $0.75 by $0.10. Quarterly revenue was reported to be $182.39 million, above analysts' expectations of $171.29 million. With a trailing EPS of $3.06 and a P/E Ratio of 8.17, Amphastar Pharmaceuticals' earnings are expected to decrease -5.73% next year, from $3.49 to $3.29 per share.

Q2 2024 Earnings Resources

AMPH Upcoming Earnings

Amphastar Pharmaceuticals' Q1 2025 earnings is scheduled for Wednesday, May 7, 2025, with a conference call scheduled at 5:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Get Amphastar Pharmaceuticals Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Amphastar Pharmaceuticals and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

AMPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AMPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Amphastar Pharmaceuticals Analyst EPS Estimates

Current Year EPS Consensus Estimate
$3.49 EPS
Next Year EPS Consensus Estimate
$3.29 EPS

Amphastar Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/7/2025
(Estimated)
-------
8/7/2024Q2 2024$0.75$0.85+$0.10$0.97$171.29M$182.39M
5/8/2024Q1 2024$0.73$0.93+$0.20$1.05$171.13M$171.84M
2/28/2024Q4 2023$0.84$0.81 -$0.03$0.94$174.90M$178.11M
11/8/2023Q3 2023$0.67$1.08+$0.41$1.25$170.65M$180.56M
8/8/2023Q2 2023$0.52$0.58+$0.06$0.67$137.20M$145.71M
5/9/2023Q1 2023$0.40$0.52+$0.12$0.54$130.50M$140.02M

Amphastar Pharmaceuticals Earnings - Frequently Asked Questions

Amphastar Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 7th, 2025 based off last year's report dates. Learn more on AMPH's earnings history.

In the previous quarter, Amphastar Pharmaceuticals (NASDAQ:AMPH) reported $0.85 earnings per share (EPS) to beat the analysts' consensus estimate of $0.75 by $0.10. Learn more on analysts' earnings estimate vs. AMPH's actual earnings.

The conference call for Amphastar Pharmaceuticals's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Amphastar Pharmaceuticals's latest earnings report can be read online.
Read Transcript

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded annual revenue of $731.97 million.

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a recorded net income of $137.54 million. AMPH has generated $3.06 earnings per share over the last four quarters.

Amphastar Pharmaceuticals (NASDAQ:AMPH) has a trailing price-to-earnings ratio of 8.17 and a forward price-to-earnings ratio of 7.02. The price/earnings-to-growth ratio is 2.19.

Amphastar Pharmaceuticals's earnings are expected to decrease from $3.49 per share to $3.29 per share in the next year, which is a -5.73% change.

More Earnings Resources from MarketBeat



This page (NASDAQ:AMPH) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners